IBDEI1FH ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,25597,2)
 ;;=^272402
 ;;^UTILITY(U,$J,358.3,25598,0)
 ;;=493.90^^145^1544^13
 ;;^UTILITY(U,$J,358.3,25598,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25598,1,4,0)
 ;;=4^493.90
 ;;^UTILITY(U,$J,358.3,25598,1,5,0)
 ;;=5^Asthma NOS
 ;;^UTILITY(U,$J,358.3,25598,2)
 ;;=^330091
 ;;^UTILITY(U,$J,358.3,25599,0)
 ;;=724.5^^145^1544^16
 ;;^UTILITY(U,$J,358.3,25599,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25599,1,4,0)
 ;;=4^724.5
 ;;^UTILITY(U,$J,358.3,25599,1,5,0)
 ;;=5^Back Pain, Chronic
 ;;^UTILITY(U,$J,358.3,25599,2)
 ;;=^12250
 ;;^UTILITY(U,$J,358.3,25600,0)
 ;;=600.00^^145^1544^14
 ;;^UTILITY(U,$J,358.3,25600,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25600,1,4,0)
 ;;=4^600.00
 ;;^UTILITY(U,$J,358.3,25600,1,5,0)
 ;;=5^BPH w/o Obstruction
 ;;^UTILITY(U,$J,358.3,25600,2)
 ;;=^334276
 ;;^UTILITY(U,$J,358.3,25601,0)
 ;;=490.^^145^1544^18
 ;;^UTILITY(U,$J,358.3,25601,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25601,1,4,0)
 ;;=4^490.
 ;;^UTILITY(U,$J,358.3,25601,1,5,0)
 ;;=5^Bronchitis NOS
 ;;^UTILITY(U,$J,358.3,25601,2)
 ;;=^17164
 ;;^UTILITY(U,$J,358.3,25602,0)
 ;;=682.8^^145^1544^21
 ;;^UTILITY(U,$J,358.3,25602,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25602,1,4,0)
 ;;=4^682.8
 ;;^UTILITY(U,$J,358.3,25602,1,5,0)
 ;;=5^Cellulitis NEC
 ;;^UTILITY(U,$J,358.3,25602,2)
 ;;=^271896
 ;;^UTILITY(U,$J,358.3,25603,0)
 ;;=585.9^^145^1544^22
 ;;^UTILITY(U,$J,358.3,25603,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25603,1,4,0)
 ;;=4^585.9
 ;;^UTILITY(U,$J,358.3,25603,1,5,0)
 ;;=5^Chronic Renal Insufficiency
 ;;^UTILITY(U,$J,358.3,25603,2)
 ;;=^332812
 ;;^UTILITY(U,$J,358.3,25604,0)
 ;;=428.0^^145^1544^19
 ;;^UTILITY(U,$J,358.3,25604,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25604,1,4,0)
 ;;=4^428.0
 ;;^UTILITY(U,$J,358.3,25604,1,5,0)
 ;;=5^CHF
 ;;^UTILITY(U,$J,358.3,25604,2)
 ;;=^54758
 ;;^UTILITY(U,$J,358.3,25605,0)
 ;;=496.^^145^1544^20
 ;;^UTILITY(U,$J,358.3,25605,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25605,1,4,0)
 ;;=4^496.
 ;;^UTILITY(U,$J,358.3,25605,1,5,0)
 ;;=5^COPD
 ;;^UTILITY(U,$J,358.3,25605,2)
 ;;=^24355
 ;;^UTILITY(U,$J,358.3,25606,0)
 ;;=414.01^^145^1544^23
 ;;^UTILITY(U,$J,358.3,25606,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25606,1,4,0)
 ;;=4^414.01
 ;;^UTILITY(U,$J,358.3,25606,1,5,0)
 ;;=5^Coronary Artery Disease
 ;;^UTILITY(U,$J,358.3,25606,2)
 ;;=^303281
 ;;^UTILITY(U,$J,358.3,25607,0)
 ;;=311.^^145^1544^25
 ;;^UTILITY(U,$J,358.3,25607,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25607,1,4,0)
 ;;=4^311.
 ;;^UTILITY(U,$J,358.3,25607,1,5,0)
 ;;=5^Depression
 ;;^UTILITY(U,$J,358.3,25607,2)
 ;;=^35603
 ;;^UTILITY(U,$J,358.3,25608,0)
 ;;=250.01^^145^1544^26
 ;;^UTILITY(U,$J,358.3,25608,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25608,1,4,0)
 ;;=4^250.01
 ;;^UTILITY(U,$J,358.3,25608,1,5,0)
 ;;=5^Diabetes, Type 1
 ;;^UTILITY(U,$J,358.3,25608,2)
 ;;=^331780
 ;;^UTILITY(U,$J,358.3,25609,0)
 ;;=250.00^^145^1544^27
 ;;^UTILITY(U,$J,358.3,25609,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25609,1,4,0)
 ;;=4^250.00
 ;;^UTILITY(U,$J,358.3,25609,1,5,0)
 ;;=5^Diabetes, Type 2
 ;;^UTILITY(U,$J,358.3,25609,2)
 ;;=^331779
 ;;^UTILITY(U,$J,358.3,25610,0)
 ;;=305.90^^145^1544^29
 ;;^UTILITY(U,$J,358.3,25610,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25610,1,4,0)
 ;;=4^305.90
 ;;^UTILITY(U,$J,358.3,25610,1,5,0)
 ;;=5^Drug Abuse-Unspec
 ;;^UTILITY(U,$J,358.3,25610,2)
 ;;=^268258
 ;;^UTILITY(U,$J,358.3,25611,0)
 ;;=305.93^^145^1544^28
 ;;^UTILITY(U,$J,358.3,25611,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25611,1,4,0)
 ;;=4^305.93
 ;;^UTILITY(U,$J,358.3,25611,1,5,0)
 ;;=5^Drug Abuse-In Remission
